← Open Payments lookup

LINDA MCCRACKEN: Open Payments

NPI 1780307850 · NEW WILMINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,814 in 157 payments from 20 companies in 2025. Trend: 2023 $2,303 · 2024 $2,839 · 2025 $2,814

Food & beverage: $2,804Education: $10
CompanyPaymentsAmount
GlaxoSmithKline, LLC.17$327
ABBVIE INC.25$326
AstraZeneca Pharmaceuticals LP11$293
Novo Nordisk Inc15$282
Lilly USA, LLC17$252
Lundbeck LLC13$247
Otsuka America Pharmaceutical, Inc.10$222
Boehringer Ingelheim Pharmaceuticals, Inc.13$177
PFIZER INC.9$177
Amgen Inc.9$161

Products named: REXULTI, TRELEGY ELLIPTA, MOUNJARO, Ozempic, FARXIGA, ELIQUIS, JARDIANCE, QULIPTA.

Industry payments across PA — which companies pay providers there.